Vyant Bio Email Format

Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees

Vyant Bio is a pharmaceutical development company based in Cherry Hill, New Jersey. It concentrates on identifying therapeutics for central nervous system and oncology-related diseases, working with small- and large-molecule candidates. The organization combines biology, engineering, and data science to model disease and advance potential therapies, often through partnerships that aim to develop and commercialize new treatments. 

Within the drug discovery space, Vyant Bio has pursued collaborations and asset transactions as part of its strategy. In July 2023, the company completed the sale of StemoniX assets to AxoSim. Earlier, it announced a collaboration with OrganoTherapeutics to accelerate 3D organoid disease modeling and identify novel therapeutics for familial Parkinson's disease.

Sign up for free to view info

Company overview Employee directory